Skip to main content
MASI
NASDAQ Industrial Applications And Services

Masimo Faces Three Stockholder Lawsuits Challenging Danaher Merger Disclosures

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$178.55
Mkt Cap
$9.358B
52W Low
$125.94
52W High
$179
52W Position info
42% above low
Off High info
at 52W high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

MASI sits 42% above its 52-week low of $125.94 on light trading volume (0.4× avg).

Summary

Masimo Corporation disclosed that three stockholder lawsuits have been filed seeking to enjoin its pending merger with Danaher Corporation, alleging inadequate disclosures in the definitive proxy statement, prompting voluntary supplemental disclosures to mitigate risks.


Key Events · Legal and Risk Events · MASI

  • Stockholder Lawsuits Filed

    Three lawsuits have been filed by purported stockholders in New York and California, challenging the adequacy of disclosures in the definitive proxy statement for the pending merger with Danaher Corporation.

  • Merger Injunction Sought

    The lawsuits allege the definitive proxy statement is inaccurate or incomplete and seek, among other remedies, an injunction to prevent the consummation of the merger.

  • Voluntary Supplemental Disclosures

    Masimo is voluntarily supplementing the definitive proxy statement to mitigate risks of delay or adverse effects on the merger, while denying any liability or wrongdoing.

  • Board Reaffirms Merger Recommendation

    The Board of Directors continues to recommend that stockholders vote 'FOR' the merger proposals, despite the new litigation.


Analysis · MASI · Industrial Applications And Services

This 8-K filing reveals new legal challenges to Masimo's proposed merger with Danaher, with three separate stockholder lawsuits filed in New York and California. These lawsuits, which seek to enjoin the merger and claim inadequate disclosures in the definitive proxy statement, introduce a material layer of risk and uncertainty to the transaction's completion. While Masimo asserts the claims are without merit and the board continues to recommend the merger, the company is voluntarily providing supplemental disclosures to address the allegations and minimize potential delays. Investors should monitor the progress of these lawsuits and any further updates regarding the merger timeline, as legal challenges can impact deal certainty and incur significant costs.

At the time of this filing, MASI was trading at $178.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.4B. The 52-week trading range was $125.94 to $179.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MASI - Latest Insights

MASI
Jun 10, 2026, 9:41 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $179.95
Real-time Price: $179.99 info
Change: +$0.040 (+0.02%) info
Market Cap: $9.423B info
MASI
May 05, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $178.58
Real-time Price: $179.99 info
Change: +$1.41 (+0.79%) info
Market Cap: $9.423B info
MASI
May 05, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $178.58
Real-time Price: $179.99 info
Change: +$1.41 (+0.79%) info
Market Cap: $9.423B info
MASI
May 04, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $178.41
Real-time Price: $179.99 info
Change: +$1.58 (+0.89%) info
Market Cap: $9.423B info
MASI
May 01, 2026, 4:30 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $178.48
Real-time Price: $179.99 info
Change: +$1.51 (+0.85%) info
Market Cap: $9.423B info